/
/
/

Nath Bio-Genes (India) Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)138.29
Volume (₹)7,446.00
High (₹)143.54
Upper Circuit162.70
Low (₹)138.00
Lower Circuit108.48
Prev Close135.59
52W High (₹)204.00
Price139.91
52W Low (₹)126.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)258.45 Cr
Div. Yield (%)1.47
PE Ratio7.06
Debt to Equity0.20
Price to Book0.36
Book Value358.06
EPS (TTM)19.26
Face Value10.00
ROE (%)6.28

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
BSHSLNSE
REGAALNSE
MGELNSE
SHEETAL-SMNSE
KOTYARKNSE
NATHBIOGENNSE
LTP
1W Low
1W High
Market cap (₹)
725+48.2 (7.12%)
676.35
728.85
3,658Cr
1702+106.2 (6.65%)
1571
1739.40
2,258Cr
98.84+4.06 (4.28%)
93.29
101.74
1,476Cr
388-13.4 (-3.34%)
380
407
951Cr
95.5+11.92 (14.26%)
83.12
97
948Cr
89.3+5.21 (6.20%)
83.25
92.09
932Cr
16.05+0.24 (1.52%)
15.52
16.45
534Cr
358+14.5 (4.22%)
346
358.55
428Cr
34.19+1.91 (5.92%)
31.69
35.75
381Cr
139.91+2.12 (1.54%)
134.20
143.54
258Cr

Key Highlights of Nath Bio-Genes (India) Ltd Balance Sheet

Nath Bio-Genes (India) Ltd balance sheet discloses shareholders' funds of ₹19Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹19Cr, and the reserves and surplus of the company is ₹629.66Cr.

The company has its non-current liabilities with total liabilities of ₹1016.87Cr as of 2025-03-31.

The current liabilities are ₹363.05Cr as of 2025-03-31. At the same time, current assets are ₹680.55Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹6.05Cr and tangible assets of ₹250.22Cr, provided in the Nath Bio-Genes (India) Ltd financial statements.